Laxoberon

Sodium picosulfate monohydrate, the active ingredient in Laxoberon, is a stimulant laxative presented as an oral formulation for oral use. It is employed to relieve occasional constipation and to cleanse the bowel before diagnostic examinations. GNH USA supplies Laxoberon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Laxoberon, a stimulant laxative, is used in conditions that require increased colonic motility or bowel cleansing. - Constipation: promotes regular bowel movements and relieves occasional constipation. - Colonoscopy preparation: provides effective bowel cleansing to allow clear visualization during colonoscopy. - Radiologic imaging preparation: clears the intestinal tract before contrast‑enhanced imaging studies.

Laxoberon may cause a range of adverse reactions, most of which are related to its stimulant activity on the colon.

Common Side Effects: - Abdominal cramps or pain - Nausea or mild vomiting - Diarrhea or loose stools - Flatulence or bloating - Thirst due to fluid loss - Mild electrolyte imbalance (e.g., low potassium)

Serious or Rare Side Effects: - Severe dehydration - Marked electrolyte disturbances (hypokalemia, hyponatremia) - Rectal bleeding or severe abdominal pain - Allergic reactions such as rash, itching, or angioedema - Rare colonic perforation - Acute renal impairment secondary to volume loss

Before prescribing Laxoberon, clinicians should evaluate patient-specific factors that may increase risk of complications. - Assess hydration status: ensure patient is adequately hydrated before use. - Review medical history: avoid in patients with known intestinal obstruction or severe inflammatory bowel disease. - Use caution in the elderly: increased susceptibility to electrolyte shifts. - Monitor electrolyte levels: especially potassium, in patients on concurrent diuretics. - Avoid concomitant use with other strong laxatives unless medically justified. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Laxoberon can interact with other medicines, altering its efficacy or increasing the risk of adverse events.

Major Interactions (Avoid): - Diuretics: may exacerbate fluid and electrolyte loss. - Cardiac glycosides (e.g., digoxin): heightened risk of hypokalemia‑related toxicity. - Other stimulant laxatives: can cause severe diarrhea and dehydration.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may reduce the laxative effect. - NSAIDs: combined gastrointestinal irritation may increase abdominal discomfort. - Corticosteroids: potential for additive electrolyte disturbances. - Magnesium‑containing antacids: may enhance laxative action and cause excess fluid loss.